国产亚洲欧美日韩俺去了,人妻无码久久精品,亚洲人成影院在线观看,亚洲AV永久无码精品表情包

美國Integrated Diagnostics
Integrated Diagnostics 正在開(kāi)發(fā)基于血液的大規模分子診斷技術(shù)，該技術(shù)通過(guò)同時(shí)監測數十到數百個(gè)疾病標記物，實(shí)現重大疾病，如肺癌和阿爾茨海默氏癥的早期檢測。該公司由系統生物學(xué)先驅 Lee Hood 博士于 2009 年 10 月創(chuàng )立，公司正致力于通過(guò)采用尖端信息學(xué)技術(shù)進(jìn)行生物標記物選擇，以及采用創(chuàng )新的具有類(lèi)似抗體特性的合成診斷和治療劑——蛋白質(zhì)催化的捕獲劑，開(kāi)發(fā)新一代個(gè)體化醫療解決方案。Integrated Diagnostics 的目標是開(kāi)發(fā)用于嚴重疾病早期檢測的新一代低成本、大規模診斷分析技術(shù)。該公司專(zhuān)注于從系統生物學(xué)角度研究包含蛋白質(zhì)、基因及其他分子的疾病病理生理學(xué)分子網(wǎng)絡(luò )。投資者包括 InterWest Partners、The Wellcome Trust 和 BioTechCube Luxembourg?；A知識產(chǎn)權由系統生物學(xué)研究所和加州理工學(xué)院獨家授權。






Integrated Diagnostics is developing large-scale, blood-based molecular diagnostics that detect important diseases like lung cancer and Alzheimer's at their earliest stages by simultaneously monitoring tens to hundreds of disease markers. The company, founded in October 2009 by systems biology pioneerDr. Lee Hood, is creating a new generation of personalized medical solutions using sophisticated informatics for biomarker selection and a novel class of synthetically created diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. Integrated Diagnostics' mission is to build a new generation of low-cost, large-scale diagnostic assays for early detection of serious diseases. The company is conceptually based on a systems view of disease where pathophysiology arises from disease-perturbed networks of proteins, genes, and other molecules. Investors include InterWest Partners, The Wellcome Trust, and BioTechCube Luxembourg. Foundational intellectual property is exclusively licensed from the Institute of Systems Biology and Caltech.